Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2026-02-12 @ 9:53 PM
Study NCT ID:
NCT05418868
Status:
RECRUITING
Last Update Posted:
2025-12-18
First Post:
2022-06-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
Sponsor:
ViiV Healthcare
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-14
Start Date Type:
ACTUAL
Primary Completion Date:
2027-06-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06-08
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-09
First Submit QC Date:
None
Study First Post Date:
2022-06-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-10
Last Update Post Date:
2025-12-18
Last Update Post Date Type:
ESTIMATED